Unexpected CD4 cell count decline in patients receiving didanosine and tenofovir-based regimens despite undetectable viral loadEugènia Negredo, Bonaventura Clotet, José Moltó et al.|AIDS|2004Cited by 114
Optimizing Research to Speed Up Availability of Pediatric Antiretroviral Drugs and FormulationsMartina Penazzato, Marissa Vicari, Rohan Hazra et al.|Clinical Infectious Diseases|2017Cited by 36
Pharmacokinetics of antiretroviral and tuberculosis drugs in children with HIV/TB co-infection: a systematic reviewTom Jacobs, Nandita Sugandhi, Elin M. Svensson et al.|Journal of Antimicrobial Chemotherapy|2020Cited by 32
Adequate exposure of 50 mg dolutegravir in children weighing 20 to 40 kg outside of sub-Sahara AfricaHylke Waalewijn, Angela Colbers, Kim Stol et al.|AIDS|2022Cited by 4